These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Topiramate in the treatment of chronic migraine. Silvestrini M; Bartolini M; Coccia M; Baruffaldi R; Taffi R; Provinciali L Cephalalgia; 2003 Oct; 23(8):820-4. PubMed ID: 14510929 [TBL] [Abstract][Full Text] [Related]
28. [Topiramate in chronic daily headache due to migraine]. Gracia-Naya M; Latorre-Jiménez AM; Ríos-Gómez C; Santos-Lasaosa S; Mauri JA; Sánchez-Valiente S; López E Rev Neurol; 2007 Oct 16-31; 45(8):456-9. PubMed ID: 17948210 [TBL] [Abstract][Full Text] [Related]
29. [Preventive treatment with topiramate enhances the quality of life of patients with migraine]. Medrano V; Sempere AP; Morera-Guitart J; Fernandez-Izquierdo S; Espinosa-Martinez J Rev Neurol; 2006 Sep 1-15; 43(5):259-63. PubMed ID: 16941422 [TBL] [Abstract][Full Text] [Related]
30. Zonisamide versus topiramate in migraine prophylaxis: a double-blind randomized clinical trial. Mohammadianinejad SE; Abbasi V; Sajedi SA; Majdinasab N; Abdollahi F; Hajmanouchehri R; Faraji A Clin Neuropharmacol; 2011; 34(4):174-7. PubMed ID: 21738025 [TBL] [Abstract][Full Text] [Related]
31. [The role of the neuromodulators in the preventive treatment of migraine]. Pascual-Gómez J Rev Neurol; 2009 Jul 1-15; 49(1):25-32. PubMed ID: 19557697 [TBL] [Abstract][Full Text] [Related]
32. Use of melatonin versus valproic acid in prophylaxis of migraine patients: A double-blind randomized clinical trial. Ebrahimi-Monfared M; Sharafkhah M; Abdolrazaghnejad A; Mohammadbeigi A; Faraji F Restor Neurol Neurosci; 2017; 35(4):385-393. PubMed ID: 28800342 [TBL] [Abstract][Full Text] [Related]
33. Effectiveness of topiramate in the prevention of childhood headaches. Hershey AD; Powers SW; Vockell AL; LeCates S; Kabbouche M Headache; 2002 Sep; 42(8):810-8. PubMed ID: 12390646 [TBL] [Abstract][Full Text] [Related]
34. Topiramate and triptans revert chronic migraine with medication overuse to episodic migraine. Mei D; Ferraro D; Zelano G; Capuano A; Vollono C; Gabriele C; Di Trapani G Clin Neuropharmacol; 2006; 29(5):269-75. PubMed ID: 16960472 [TBL] [Abstract][Full Text] [Related]
35. [Preventive treatment of chronic migraine with zonisamide: a study in patients who are refractory or intolerant to topiramate]. Pascual-Gómez J; Alañá-García M; Oterino A; Leira R; Láinez-Andrés JM Rev Neurol; 2008 Nov 1-15; 47(9):449-51. PubMed ID: 18985592 [TBL] [Abstract][Full Text] [Related]
36. Flunarizine versus topiramate for chronic migraine prophylaxis: a randomized trial. Lai KL; Niddam DM; Fuh JL; Chen SP; Wang YF; Chen WT; Wu JC; Wang SJ Acta Neurol Scand; 2017 Apr; 135(4):476-483. PubMed ID: 27306581 [TBL] [Abstract][Full Text] [Related]
37. [Topiramate in the treatment of chronic migraine]. Azimova IuE; Tabeeva GR Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(12):31-5. PubMed ID: 23388589 [TBL] [Abstract][Full Text] [Related]
38. Low-dose topiramate plus sodium divalproate for positive responders intolerant to full-dose monotherapy. Krymchantowski AV; Jevoux Cda C Headache; 2012 Jan; 52(1):129-32. PubMed ID: 22085390 [TBL] [Abstract][Full Text] [Related]
39. Topiramate vs divalproex sodium in the preventive treatment of migraine: a prospective "real-world" study. Krymchantowski AV; Jevoux CC Headache; 2011 Apr; 51(4):554-8. PubMed ID: 21457240 [TBL] [Abstract][Full Text] [Related]